Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 10584133 Thienopyrimidinone compounds

Patent 10584133 was granted and assigned to BioTheryX on March, 2020 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Applicant

0

Current Assignee

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Robert Sullivan0

Kyle W. H. Chan0

Leah Fung0

Paul E. Erdman0

Aparajita Hoskote Chourasia0

Eduardo Torres0

Frank Mercurio0

Imelda Lam0

Date of Patent

March 10, 2020

0

Patent Application Number

163684090

Date Filed

March 28, 2019

0

Patent Citations

US Patent 10336771 Compounds targeting proteins, compositions, methods, and uses thereof

US Patent 10040804 Compounds targeting proteins, compositions, methods, and uses thereof

0

US Patent 10406165 Compounds targeting proteins, compositions, methods, and uses thereof

0

Patent Primary Examiner

Daniel R Carcanague

0

Patent abstract

The present disclosure provides compounds that modulate protein function and/or restore protein homeostasis. The disclosure provides methods of modulating protein-mediated diseases, disorders, conditions, or responses. Compositions, including in combination with other therapeutic agents, are provided.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10584133 Thienopyrimidinone compounds

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool